141 related articles for article (PubMed ID: 6871825)
1. A new working formulation of non-Hodgkin's lymphomas. A retrospective study of the new NCI classification proposal in comparison to the Rappaport and Kiel classifications.
Krueger GR; Medina JR; Klein HO; Konrads A; Zach J; Rister M; Janik G; Evers KG; Hirano T; Kitamura H; Bedoya VA
Cancer; 1983 Sep; 52(5):833-40. PubMed ID: 6871825
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
[TBL] [Abstract][Full Text] [Related]
3. A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.
Monfardini S; Rilke F; Valagussa P; Bajetta E; Canetta R; Buzzoni R; Giardini R; Viviani S
Eur J Cancer Clin Oncol; 1984 May; 20(5):609-17. PubMed ID: 6203753
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin's lymphomas: a simplified classification scheme.
Krueger GR; Papadakis T; Medina JR
Anticancer Res; 1984; 4(3):103-8. PubMed ID: 6465846
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years.
Lieberman PH; Filippa DA; Straus DJ; Thaler HT; Cirrincione C; Clarkson BD
Am J Med; 1986 Sep; 81(3):365-80. PubMed ID: 3752139
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: study based on the clinicopathologic relations found in the EORTC trial (20751).
De Wolf-Peeters C; Caillou B; Diebold J; van Heerde P; van Unnik JA; van den Oord JJ; van Glabbeke M; Somers R
Eur J Cancer Clin Oncol; 1985 May; 21(5):579-84. PubMed ID: 4007023
[TBL] [Abstract][Full Text] [Related]
7. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
[TBL] [Abstract][Full Text] [Related]
8. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
9. Clinico-pathological correlations in the Kiel classification of non-Hodgkin's lymphomata in children.
Garwicz S; Landberg T; Lindberg LG; Akerman M
Scand J Haematol; 1978 Feb; 20(2):171-80. PubMed ID: 635468
[TBL] [Abstract][Full Text] [Related]
10. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
[TBL] [Abstract][Full Text] [Related]
11. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.
Cancer; 1982 May; 49(10):2112-35. PubMed ID: 6896167
[TBL] [Abstract][Full Text] [Related]
12. Relation between enzymatic activities and the degree of malignancy of human lymphomas.
Vezzoni P; Giardini R; Raineri M; Pozzi MR; Lucchini R; Vezzoni MA; Clerici L; Besana C; Rugarli C; Rilke F
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):945-50. PubMed ID: 4043177
[TBL] [Abstract][Full Text] [Related]
13. Histopathological correlation of the Kiel with the original Rappaport classification of malignant non-hodgkin lymphomas.
Krüger GR; Grisar T; Lennert K; Schwarze EW; Brittinger G
Blut; 1981 Sep; 43(3):167-81. PubMed ID: 7343013
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of three pathologic classifications (Rappaport, LSG and Working Formulation) for the treatment of non-Hodgkin's lymphoma].
Shibuya H; Kamiyama R; Umehara I; Okada Y; Sato S; Yoshimatsu S; Horiuchi J; Suzuki S
Gan No Rinsho; 1985 Nov; 31(14):1757-61. PubMed ID: 4087381
[TBL] [Abstract][Full Text] [Related]
15. Morphological classification of non-Hodgkin malignant lymphoma. II. Comparison between Rappaport's classification and the Kiel classification.
Glimelius B; Hagberg H; Sundström C
Scand J Haematol; 1983 Jan; 30(1):13-24. PubMed ID: 6836219
[TBL] [Abstract][Full Text] [Related]
16. [Histological classification of malignant non-Hodgkin's lymphomas and patient survival: the Kiel classification versus the working formulation].
Nizze H; Bühring U
Verh Dtsch Ges Pathol; 1992; 76():110-6. PubMed ID: 1283239
[TBL] [Abstract][Full Text] [Related]
17. A critical analysis of the classifications of non-Hodgkin's lymphomas.
Nathwani BN
Cancer; 1979 Aug; 44(2):347-84. PubMed ID: 383253
[TBL] [Abstract][Full Text] [Related]
18. The problem of classifying lymphomas: an orderly prescription for progress.
Berard CW; Hutchison RE
Ann Oncol; 1997; 8 Suppl 2():3-9. PubMed ID: 9209632
[TBL] [Abstract][Full Text] [Related]
19. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
Stacher A; Heinz R; Waldner R; Böhnel J
Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the Kiel classification of malignant non-Hodgkin's lymphomas.
Bettini R; Chelazzi G
Tumori; 1979 Apr; 65(2):207-13. PubMed ID: 462572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
